Osteonic Co. Ltd (226400) — Capital Reinvestment Ratio

Latest as of September 2025: 1.39x

Osteonic Co. Ltd (226400) has a Capital Reinvestment Ratio of 1.39x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.09 Billion) in capital expenditures (₩1.52 Billion). See 226400 equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.39x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.09 Billion
KRW

Capital Expenditures

₩1.52 Billion
KRW

Data as of

Sep 2025
Most recent filing

Osteonic Co. Ltd Capital Reinvestment Ratio (2018–2024)

This chart tracks Osteonic Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. Check cash flow reinvestment rate of Osteonic Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Osteonic Co. Ltd (2018–2024)

Year-by-year Capital Reinvestment Ratio for Osteonic Co. Ltd from 2018 to 2024. For live market cap and broader valuation context, see Osteonic Co. Ltd (226400) total market value.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 1.49x ₩4.72 Billion ₩7.05 Billion ▼ -11.3%
2023 1.68x ₩4.14 Billion ₩6.97 Billion ▲ +1294.5%
2022 0.12x ₩3.99 Billion ₩481.34 Million ▼ -62.1%
2021 0.32x ₩2.95 Billion ₩939.46 Million ▼ -7.5%
2020 0.34x ₩2.75 Billion ₩949.15 Million ▼ -97.9%
2018 16.58x ₩317.53 Million ₩5.26 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow